Article
Inhibition of p107 alleviates liver steatosis by reducing de novo fatty acid synthesis
2026-04-16
Abstract excerpt
Metabolic dysfunction–associated steatotic liver disease (MASLD) is characterized by excessive hepatic lipid accumulation driven by increased de novo lipogenesis (DNL) and impaired lipid oxidation. p107, a member of the retinoblastoma (Rb) family, extensively studied in the context of cell cycle regulation and adipocyte differentiation recently has been identified as a metabolic regulator controlling thermogenic a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0ee1a6e4-cedf-5944-be0a-cc7d0ff0b892
- DOI
- 10.64898/2026.04.14.718271
